Why Evo Peptides Is the Best Place to Buy GLP-3 RT for Research
Six standards. All six met. Every batch.
GLP-3 RT Lot-Specific Purity and Price by Vial
| Vial | HPLC Purity | Identity | Price | Cost / mg | Best For |
|---|---|---|---|---|---|
| 15mg | 99.27% | MS confirmed | $69.95 | $4.66 | Pilots, supplier validation |
| 20mg | 99.85% | MS confirmed | $89.95 | $4.50 | Mid-length studies |
| 30mg | 99.91% | MS confirmed | $134.95 | $4.50 | Longer studies, single-lot runs |
| 30mg (2 × 15mg) | Per lot COA | MS confirmed | $134.95 | $4.50 | 2-vial pack for split arms |
- Full COAs: evopeptidesus.com/coas.
- Reviewable before purchase. No request needed.
- Order multiples at once. Same batch. Same lot.
Why a 95% Purity Floor Fails GLP-3 RT Research
- 95% = up to 5% uncharacterized material.
- Likely impurities: truncated sequences, de-lipidated species.
- De-lipidated material = altered pharmacokinetics in models.
- Result: shifted dose-response curves.
- Result: higher inter-experiment variability.
- Most exposed: glucagon-receptor endpoints.
- 99.91% = impurity load cut roughly 50×.
High-fidelity experimental reproduction starts at lot-specific ≥99%.
Peer-to-Peer-Only Payment: The Vendor Red Flag
- Venmo, Cash App, or Zelle as the only option.
- Usually means lost or denied card processing.
- No chargeback. No dispute rights. No recourse.
- Money moves before any accountability exists.
- Conventional domestic credit/debit card checkout.
- Card-network buyer protection intact.
- App payments optional. Never required.
- Verified researcher account on every order.
GLP-3 RT Compound Profile
| Attribute | Detail |
|---|---|
| Catalog name | GLP-3 RT (also GLP3, GLP3-RT, RT3) |
| Development code | LY3437943 (retatrutide) |
| Class | Triple incretin agonist: GLP-1R / GIPR / GCGR |
| Length | 39 amino acids |
| Modification | C20 fatty diacid via linker (albumin binding) |
| Molecular weight | ~4,731 Da |
| Reference standard | None — MS identity required |
| Regulatory | Investigational Not FDA-approved. Not scheduled. |
| Supplied as | Lyophilized powder · Research Use Only |
Mechanism and trial background: GLP-3 RT research guide.
6-Point GLP-3 RT COA Checklist
All six. Or no purchase.
- HPLC purity ≥99%Chromatogram attached. Lot-specific value, not a floor.
- Mass spec identityESI-MS or MALDI-TOF. Intact mass near 4,731 Da, lipid included.
- Named third-party labSeparate legal entity. Verifiable contact details.
- Lot number matchCOA lot = vial label. Generic COAs prove nothing.
- Recent test dateWithin ~12 months. Tied to current stock.
- Public before purchasePosted on the product or COA page. No "request after order."
7 Red Flags When Buying GLP-3 Online
| Red Flag | Why It Matters | What Good Looks Like |
|---|---|---|
| P2P-only payment | No buyer protection. Often lost card processing. | Card checkout, dispute rights intact |
| "≥95% purity" floor | Marketing, not measurement | Lot-specific ≥99% values |
| No mass spec | Purity without identity | MS confirming ~4,731 Da |
| "COA on request" | No pre-purchase verification | COAs public before checkout |
| Unnamed or in-house lab | Conflict of interest | Named independent lab |
| No US operation | No entity, no address, no recourse | Registered US business, domestic fulfillment |
| Dosing or "results" talk | Outside the RUO framework | Strict in vitro research labeling |
Related Incretin-Class Research Compounds
| Compound | Class | Receptors | Evo Format | Price |
|---|---|---|---|---|
| GLP-3 RT | Triple agonist | GLP-1 · GIP · GCG | 15 / 20 / 30mg | From $69.95 |
| GLP-3 RT 30mg (2 × 15mg) | Triple agonist | GLP-1 · GIP · GCG | 2-vial pack | $134.95 |
| GLP-2 TRZ | Dual agonist | GLP-1 · GIP | 15 / 30mg | From $49.95 |
| GLP-2 TRZ 30mg (2 × 15mg) | Dual agonist | GLP-1 · GIP | 2-vial pack | $74.95 |
| GLP-1 SM | Single agonist | GLP-1 | Not stocked | — |
| Cagrilintide | Amylin analog | AMY / CTR | Not stocked | — |
GLP-3 RT + GLP-2 TRZ
- Triple vs dual: isolates the glucagon-receptor contribution.
- One supplier. One lab. One COA method. Fewer confounds.
- Study notes: GLP-3 RT vs GLP-2 TRZ.
- Stack toward free shipping at $200+ and 10% off at 10+ vials.
What GLP-3 RT Is Studied For in Preclinical Research
Laboratory Storage & Handling
Lyophilized
- −20 °C. Long-term.
- Sealed. Dark. Desiccant.
- Minimize temperature cycling.
In solution (in vitro)
- Solvent: sterile water or 0.1–1% sterile acetic acid.
- Add down the vial wall. No vortexing.
- Gentle swirl. 5–10 minutes.
- Aliquot to single-use volumes. Store at −80 °C.
- No repeated freeze-thaw.
Full protocols: peptide storage guide · peptide half-life chart.
GLP-3 RT Legal & Regulatory Status (September 2026)
- Not FDA-approved. Investigational.
- Not scheduled. Not a controlled substance.
- Sponsor timeline: Eli Lilly plans a BLA submission in Q1 2027.
- Legal channel: Research Use Only labeling, in vitro work.
- Separate from compounding: 503A lists govern pharmacies, not RUO suppliers.
- Not permitted: human or veterinary administration.
Channel differences: research vs compounded peptides.
How to Securely Buy Research GLP-3 RT From Evo Peptides
- Create a verified account21+. Research-use acknowledgment.
- Review the lot COAOn the product page or the COA library.
- Pick a size15mg, 20mg, or 30mg. Multiples ship from one lot.
- Pay by cardCredit or debit. Dispute protection intact.
- Order before 3:00 PM CSTShips same day from Wisconsin. Tracked.
Frequently Asked Questions
What is the best place to buy GLP3 for research?
Is GLP-3 RT the same as retatrutide?
How much does GLP-3 RT cost at Evo Peptides?
Is GLP-3 RT legal to buy for research in the USA?
What must a GLP-3 RT COA contain?
Why avoid vendors that only take Venmo, Cash App, or Zelle?
Why does a 95% purity floor matter?
How fast does Evo Peptides ship GLP-3 RT?
What's the difference between GLP-3 RT and GLP-2 TRZ?
How should GLP-3 RT be stored in the lab?
- Coskun T, et al. LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metab. 2022. doi.org/10.1016/j.cmet.2022.07.013
- Jastreboff AM, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023. nejm.org/doi/full/10.1056/NEJMoa2301972
- Eli Lilly. TRIUMPH-5, NCT06662383. clinicaltrials.gov/study/NCT06662383
- HCPLive. Retatrutide meets Phase 3 weight-loss endpoints in 2 obesity trials (July 23, 2026). hcplive.com
- FDA. Bulk Drug Substances Used in Compounding Under Section 503A. fda.gov